Baxter acquires hemophilia assets, wins IDE for hemodialysis system November 20, 2010 By MassDevice staff Leave a Comment Baxter International Inc. (NYSE:BAX) notched a pair of wins over the past 24 hours, acquiring Archemix Corp.’s hemophilia assets and winning an investigational device exemption for a home hemodialysis system from the Food & Drug Administration.